Healwell AI (DB:6H90) - Aandelenkoers, Nieuws & Analyse

6H90 Overzicht aandelen

Healwell AI Inc., een technologiebedrijf in de gezondheidszorg, richt zich op AI en data science voor preventieve zorg.

6H90 fundamentele analyse
Sneeuwvlok Score
Waardering	1/6
Toekomstige groei	2/6
Prestaties in het verleden	0/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

Verhandeld tegen 5.9% onder onze schatting van de reële waarde

De omzet zal naar verwachting met 60.26% per jaar groeien

Risicoanalyse

Aandeelhouders zijn het afgelopen jaar substantieel verwaterd

Heeft minder dan 1 jaar cash runway

Momenteel verlieslatend en er wordt niet verwacht dat dit de komende 3 jaar winstgevend zal worden.

Volatiele aandelenkoers in de afgelopen 3 maanden

Healwell AI Inc. Concurrenten

VITA 34

XTRA:V3V

€79.5m

SYNLAB

HMSE:SYAB

€2.4b

MEDICLIN

XTRA:MED

€114.0m

Fresenius SE KGaA

XTRA:FRE

€18.8b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Healwell AI
Historische aandelenkoersen
Huidige aandelenkoers	CA$0.88
52 Week Hoogtepunt	CA$2.43
52 Week Laag	CA$0.42
Bèta	-1.12
11 maand verandering	-9.48%
3 maanden verandering	-36.61%
1 Jaar Verandering	74.21%
33 jaar verandering	-32.46%
5 jaar verandering	n/a
Verandering sinds IPO	-53.29%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	6H90	DE Healthcare	DE Markt
7D	-0.5%	1.2%	1.0%
1Y	74.2%	24.2%	19.0%

Rendement versus industrie: 6H90 overtrof de German Healthcare industrie, die het afgelopen jaar een rendement 10 % opleverde.

Rendement versus markt: 6H90 overtrof de German markt, die het afgelopen jaar een rendement opleverde van 13.8 %.

Prijsvolatiliteit

Is 6H90's price volatile compared to industry and market?
6H90 volatility
6H90 Average Weekly Movement	9.7%
Healthcare Industry Average Movement	3.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.0%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: De aandelenkoers van 6H90 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 10% ) van 6H90 is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen German.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2012	102	Alex Dobranowski	www.healwell.ai

Healwell AI Inc., een technologiebedrijf in de gezondheidszorg, richt zich op AI en data science voor preventieve zorg. Het biedt een AI-ondersteund beslissingsondersteunend platform voor zorgverleners. Healwell AI Inc. heeft een strategische alliantieovereenkomst met WELL Health Technologies Corp om de groei en ontwikkeling van AI-gebaseerde technologieën voor de gezondheidszorg te versterken.

Healwell AI Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Healwell AI zich tot de beurswaarde?
6H90 fundamentele statistieken
Marktkapitalisatie	€148.19m
Inkomsten(TTM)	-€11.72m
Inkomsten(TTM)	€9.05m

16.4x

P/S-verhouding

-12.6x

Koers/Winstverhouding

Is 6H90 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
6H90 resultatenrekening (TTM)
Inkomsten	CA$13.58m
Kosten van inkomsten	CA$7.46m
Brutowinst	CA$6.13m
Overige uitgaven	CA$23.71m
Inkomsten	-CA$17.58m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.11
Brutomarge	45.10%
Nettowinstmarge	-129.44%
Schuld/Eigen Vermogen Verhouding	23.8%

Hoe presteerde 6H90 op de lange termijn?

Bekijk historische prestaties en vergelijking

6H90 Overzicht aandelen

Beloningen

Risicoanalyse

Healwell AI Inc. Concurrenten

XTRA:V3V

€79.5m

HMSE:SYAB

€2.4b

XTRA:MED

€114.0m

XTRA:FRE

€18.8b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

New minor risk - Financial position

Second quarter 2024 earnings released

Healwell AI Inc. to Report Q2, 2024 Results on Aug 12, 2024

Healwell AI Inc. (TSX:AIDX) acquired 20% stake in Mci Polyclinic Group Inc.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of VeroSource Solutions Inc.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Recent updates

New minor risk - Financial position

Second quarter 2024 earnings released

Healwell AI Inc. to Report Q2, 2024 Results on Aug 12, 2024

Healwell AI Inc. (TSX:AIDX) acquired 20% stake in Mci Polyclinic Group Inc.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of VeroSource Solutions Inc.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc. announced that it has received CAD 20.00025 million in funding

First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.14 loss in 1Q 2023)

Healwell AI Inc. to Report Q1, 2024 Results on May 14, 2024

Healwell AI Inc. announced that it expects to receive CAD 16.000065 million in funding

Healwell AI Inc., Annual General Meeting, Jun 25, 2024

Healwell AI Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.56 loss per share (vs CA$0.42 loss in FY 2022)

Healwell AI Inc. to Report Q4, 2023 Results on Mar 28, 2024

Healwell AI Inc. Announces Executive Changes

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

New major risk - Shareholder dilution

Healwell AI Inc. has completed a Composite Units Offering.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of an unknown majority stake in Pentavere Research Group Inc. Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire an unknown stake in Pentavere Research Group Inc. for CAD 5.9 million.

Third quarter 2023 earnings released: CA$0.14 loss per share (vs CA$0.18 loss in 3Q 2022)

Healwell Ai Inc. Appoints Mark Findlay as Senior Vice President of Sales and Marketing for Canada

Healwell AI Inc. to Report Q3, 2023 Results on Nov 15, 2023

Healwell AI Inc. announced that it has received CAD 3.00024 million in funding

Less than half of directors are independent

Healwell Al Inc. Announces Board and Executive Changes

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. Announces Sven Grail and George Christodoulou, the Former Co-Chairs, Did Not Stand for Re-Election

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: CA$0.21 loss per share (vs CA$0.084 loss in 2Q 2022)

MCI Onehealth Technologies Inc., Annual General Meeting, Sep 21, 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

MCI Onehealth Technologies Inc. announced that it has received CAD 1.5 million in funding

First quarter 2023 earnings released: CA$0.15 loss per share (vs CA$0.086 loss in 1Q 2022)

MCI Onehealth Technologies Inc. Announces Changes to Management Team Structure

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

MCI Onehealth Technologies Inc. Expands Data Insights Offering with Innovative AI-driven Continuing Medical Education

Second quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.058 loss in 2Q 2021)

MCI Onehealth Technologies Inc. to Report Q2, 2022 Results on Aug 15, 2022

MCI Onehealth Technologies Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.054 loss in 1Q 2021)

MCI Onehealth Technologies Inc. to Report Q1, 2022 Results on May 16, 2022

Less than half of directors are independent

MCI Onehealth Technologies Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CA$0.33 loss per share (vs CA$0.027 loss in FY 2020)

MCI Onehealth Technologies Inc. Provides Revenue Guidance for Fiscal 2022

MCI Onehealth Appoints Jennifer Foster as Chief Operating Officer with Mandate to Support Expansion of Tech and Data Offerings

Third quarter 2021 earnings released: CA$0.11 loss per share

Co-Founder & Co-Executive Chair recently bought €58k worth of stock

Second quarter 2021 earnings released

MCI Onehealth Technologies Inc. (TSX:DRDR) acquired a 9% stake in ReGen Scientific Inc.

Rendement voor aandeelhouders